| Description |
1 online resource (1 PDF file (xx, 72 pages)) : illustrations |
| Contents |
Workshop overview -- Current diagnostic challenges in cancer care -- Ensuring the quality and accessibility of diagnostic expertise and technologies -- Quality improvement efforts -- Integration and collaboration of specialties -- Wrap-up |
| Summary |
Rapid advances in cancer research, the development of new and more sophisticated approaches to diagnostic testing, and the growth in targeted cancer therapies are transforming the landscape of cancer diagnosis and care. These innovations have contributed to improved outcomes for patients with cancer, but they have also increased the complexity involved in diagnosis and subsequent care decisions. To examine opportunities to improve cancer diagnosis and care, the National Academies of Sciences, Engineering, and Medicine developed a two-workshop series. The first workshop, held on February 12-13, 2018, in Washington, DC, focused on potential strategies to ensure that patients have access to appropriate expertise and technologies in oncologic pathology and imaging to inform their cancer diagnosis and treatment planning, as well as assessment of treatment response and surveillance. This publication chronicles the presentations and discussions at the workshop |
| Bibliography |
Includes bibliographical references |
| Notes |
This activity was supported by Contract No. 200-2011-38807 (Task Order No. 0051) and Contract No. HHSN263201200074I (Task Order No. HHSN26300120) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research, American Cancer Society, American College of Radiology, American Society of Clinical Oncology, Association of American Cancer Institutes, Bristol-Myers Squibb, Cancer Support Community, CEO Roundtable on Cancer, Flatiron Health, Helsinn Therapeutics (U.S.), Inc., LIVESTRONG Foundation, Merck, National Comprehensive Cancer Network, Novartis Oncology, Oncology Nursing Society, and Pfizer Inc. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project |
|
Online resource; title from PDF title page (viewed February 2, 2019) |
| Subject |
Cancer -- Diagnosis -- Congresses
|
|
Diagnostic imaging -- Congresses
|
|
Cancer -- Treatment -- Congresses
|
|
Cancer -- Patients -- Congresses
|
|
Decision making -- Mathematical models.
|
|
Interprofessional relations.
|
|
Neoplasms -- diagnosis
|
|
Neoplasms -- therapy
|
|
Medical Oncology -- trends
|
|
Decision Support Techniques
|
|
Interprofessional Relations
|
|
MEDICAL -- Oncology -- General.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Cancer -- Diagnosis.
|
|
Cancer -- Patients.
|
|
Cancer -- Treatment.
|
|
Diagnostic imaging.
|
| Genre/Form |
Conference papers and proceedings.
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
| Form |
Electronic book
|
| Author |
Patlak, Margie, author
|
|
Nass, Sharyl J., author
|
|
National Cancer Policy Forum (U.S.), issuing body.
|
|
Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies (Workshop) (2018 : Washington, D.C.)
|
| ISBN |
9780309478281 |
|
0309478286 |
|
9780309478311 |
|
0309478316 |
|
